The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction

April 18, 2021 updated by: Elif Gezginci, Saglik Bilimleri Universitesi

The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction of Intensive Care Nurses During the COVID-19 Pandemic : A Randomized Controlled Study

The Covid-19 pandemic has affected global health systems and required healthcare professionals to show high performance. In this process, the mental health of intensive care nurses, who undertake the biggest burden in health systems, is negatively affected by the high working hours and patient care burden during the pandemic. When the literature is reviewed, pessimistic thinking, feeling hopeless and not enjoying life at more exacerbated levels can be observed in intensive care nurses. It is concluded that studies are needed to increase the motivation of intensive care nurses during the Covid-19 pandemic.In this study, it was aimed to evaluate the effect of motivational messages on optimism, hopelessness and life satisfaction of intensive care nurses during the Covid-19 pandemic.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey, 34668
        • Elif Gezginci

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • agreeing to participate in the study
  • being a nurse
  • working in intensive care during the COVID-19 pandemic

Exclusion Criteria:

  • underfilling or not fill out forms and scales

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Motivational messages
Participants in the motivational group were sent to motivational messages to their mobile phones for 21 days.
Other: Motivational messages
Participants in the motivational group were sent to motivational messages to their mobile phones for 21 days.
NO_INTERVENTION: Control group
The control group did not receive any intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Optimistic level assessed by the Life Orientation Test
Time Frame: 21 days after from baseline
The primary endpoint of this study was the difference between groups in terms of Life Orientation Test scores 21 days after. The scale consists of a total of 10 items. The range of scores obtained from the scale varies between 6-30 points. Low scores indicate pessimism, while high scores indicate optimism.
21 days after from baseline
Hopelessness level assessed by the Beck Hopelessness Scale
Time Frame: 21 days after from baseline
The primary endpoint of this study was the difference between groups in terms of Beck Hopelessness Scale scores 21 days after. The scale consists of a total of 20 items..The range of scores obtained from the scale varies between 0-20 points. High scores indicate that the level of hopelessness is also high.
21 days after from baseline
Life satisfaction assessed by the Satisfaction with Life Scale
Time Frame: 21 days after from baseline
The primary endpoint of this study was the difference between groups in terms of Satisfaction with Life Scale scores 21 days after. The scale consists of a total of 5 items.The range of scores obtained from the scale varies between 5-25 points. As the total score obtained from the scale increases, life satisfaction level also increases.
21 days after from baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Saglik Bilimleri Universitesi

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2021

Primary Completion (ACTUAL)

March 1, 2021

Study Completion (ACTUAL)

March 31, 2021

Study Registration Dates

First Submitted

February 8, 2021

First Submitted That Met QC Criteria

February 8, 2021

First Posted (ACTUAL)

February 12, 2021

Study Record Updates

Last Update Posted (ACTUAL)

April 20, 2021

Last Update Submitted That Met QC Criteria

April 18, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 2021/47-31

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Motivation

Clinical Trials on Motivational messages

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe